5 Stocks That Will Prosper in a Bear Market

5 Stocks That Will Prosper in a Bear Market

The stock market's wild swings over the past few months have some calling for a swift V-shaped recovery and others forecasting the start of a new bear market. Of course, it's impossible to know for certain who's correct, but it doesn't hurt to prepare for either eventuality by shoring up your portfolio with some defensive, bear market stocks.Any seasoned trader will tell you that a bear market is an opportunity. They tend to be shorter than bull markets, making them worth investing in if you can wait it out. With that said, there are plenty of risks that come along with a bear market.Perhaps the best strategy for bear market investors is to keep some powder dry to take advantage of opportunities. As the summer earnings season approaches, uncertainty will start to creep in. Second-quarter results will mark the first time investors have had something concrete to price stocks on since...

Should You Buy United Airlines Stock? 3 Pros, 3 Cons

Now is not a great time to be invested in the airline industry. Companies like United Airlines (NASDAQ:UAL) have been hit hard by the coronavirus pandemic. And recent news about United Airlines stock has been mixed.On the one hand, United Airlines stock is trading higher than it was in March and April. The company is adding more summer flights to its schedule and passengers are starting to fly once again. The company's debt offering also saw a positive reaction.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut the coronavirus doesn't seem to be going anywhere, and rising cases in several states has many people worried that the U.S. is headed for another round of shutdowns. Let's look at three pros and three cons of investing in United Airlines stock. 3 Pros for UAL StockAirlines Passengers are Starting to Return: The good news for American Airlines is that it seems to...

The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) * Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) * Cardiff Oncology Inc (NASDAQ: CRDF) * Cerus Corporation (NASDAQ: CERS) * Dynavax Technologies Corporation (NASDAQ: DVAX) * ESSA Pharma Inc (NASDAQ: EPIX) * Fennec Pharmaceuticals Inc (NASDAQ: FENC) * Forma Therapeutics Holdings Inc (NASDAQ: FMTX) * Horizon Therapeutics PLC (NASDAQ: HZNP) * IGM Biosciences Inc (NASDAQ: IGMS) * Immunovant Inc (NASDAQ: IMVT) * Inovio Pharmaceuticals Inc (NASDAQ: INO) * Keros Therapeutics Inc (NASDAQ: KROS) * KITOV PHARMA LT/S ADR (NASDAQ: KTOV) * Liquidia Technologies Inc (NASDAQ: LQDA) * Meridian Bioscience, Inc. (NASDAQ: VIVO) * Novavax, Inc. (NASDAQ: NVAX) * Ocular Therapeutix Inc (NASDAQ: OCUL) * ORIC Pharmaceuticals Inc (NASDAQ: ORIC) * Pliant Therapeutics Inc (NASDAQ: PLRX) * Protagonist Therapeutics Inc (NASDAQ: PTGX) * Relmada Therapeutics Inc (NASDAQ: RLMD) *...

PG&E Raises More Than $5 Billion in Shares, Equity Units

(Bloomberg) -- PG&E Corp. raised more than $5 billion in a common share and equity unit offering to help finance its exit from the biggest utility bankruptcy in U.S. history.The California power giant sold more than 420 million shares at $9.50 each, it said in a statement dated Friday, representing a 2.4% discount to Thursday’s close of $9.73. The share sale, as well as separate offering of equity units, which have a coupon of 5.50%, netted the company about $5.15 billion, according to the statement.The effort is one the year’s largest stock offerings and part of the company’s plan to raise $9 billion in equity to help pay for claims from wildfires through its Chapter 11 case. PG&E has also raised more than $13 billion in the debt markets to finance its bankruptcy, which began after its equipment sparked deadly blazes in Northern California.PG&E said it expects to emerge from Chapter...

Await Pullback Before Buying ‘Too Hot to Touch’ DocuSign Stock

Many tech stocks have won big during the novel coronavirus pandemic. But few can match the epic run of DocuSign (NASDAQ:DOCU). Since January, shares have soared from around $76 per share, to $167 per share today. And over the past twelve months, the stock has rallied nearly 216%.Source: Sundry Photography / Shutterstock.com But now, with shares just a few dollars shy of their all-time highs, is there more left in the tank?Yes and no. From the bull's perspective, there's good reason why shares could head higher. As our own Louis Navellier recently put it, "the new normal will be good news for DocuSign." Post-pandemic, employers now realize the many benefits of a fully remote workforce. This could help accelerate the "work-from-home" trend. Even as the outbreak enters the rearview mirror. That means a permanent pivot from pen-and-ink to electronic signatures.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOn the other...